#Cytora

Acquisitions: #Accenture > #IAMConcepts; #AEVEX > #RapidFlight’s assets; #AppliedSystems > #Cytora; #Atlassian > #TheBrowser; #ChamberlainGroup > #ArrowTru-Line; #EnergyHob > #BridgetoRenewables; #F5 > #CalypsoAI; #GoodData > #UnderstandLabs; #iCIMS > #Apli; #Magnite > #streamr.ai

Cytora Unveils Promising Phase 1 Data on Stem Cell Therapy for MSA Cytora presents exciting Phase 1 results showing safety and potential efficacy of stem cell treatment for patients with Multiple System Atrophy at 2025 Boston congress.

Cytora Unveils Promising Phase 1 Data on Stem Cell Therapy for MSA #Israel #stem_cells #MSA #Cytora #Yoqne'am

Cytora Unveils Promising Phase 1/2a Trial Results for Innovative Stem Cell Therapy in Diabetic Foot Ulcers Cytora announces significant success in a Phase 1/2a trial using hOMSCs for treating diabetic foot ulcers, hinting at a revolutionary approach in stem cell therapy.

Cytora Unveils Promising Phase 1/2a Trial Results for Innovative Stem Cell Therapy in Diabetic Foot Ulcers #Israel #Diabetic_Foot_Ulcers #Yokneam #Cytora #Stem_Cell_Treatment